RBC Capital Initiates Coverage On Guardant Health with Outperform Rating, Announces Price Target of $185

Guardant Health

Guardant Health

GH

0.00

RBC Capital analyst Dan Leonard initiates coverage on Guardant Health (NASDAQ: GH) with a Outperform rating and announces Price Target of $185.